Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
JAK3 mutation
i
Other names:
JAK3, Janus Kinase 3, Tyrosine-Protein Kinase JAK3, Leukocyte Janus Kinase, JAK-3, L-JAK, Janus Kinase 3 (A Protein Tyrosine Kinase Leukocyte), JAK3_HUMAN, JAKL, LJAK
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3718
Related biomarkers:
Mutation
CNA
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
JAK3 mutation
Non Small Cell Lung Cancer
JAK3 mutation
Non Small Cell Lung Cancer
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
JAK3 mutation
Prolymphocytic Leukemia
JAK3 mutation
Prolymphocytic Leukemia
venetoclax + ruxolitinib
Sensitive: C3 – Early Trials
venetoclax + ruxolitinib
Sensitive
:
C3
venetoclax + ruxolitinib
Sensitive: C3 – Early Trials
venetoclax + ruxolitinib
Sensitive
:
C3
JAK3 mutation
T Acute Lymphoblastic Leukemia
JAK3 mutation
T Acute Lymphoblastic Leukemia
tofacitinib
Resistant: C4 – Case Studies
tofacitinib
Resistant
:
C4
tofacitinib
Resistant: C4 – Case Studies
tofacitinib
Resistant
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.